Camrelizumab With Chemotherapy in Adults With Medically Inoperable Early Stage NSCLC
Status:
Recruiting
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
The purpose of this study is to assess the efficacy and safety of Camrelizumab plus
chemotherapy in the treatment of adult participants with medically inoperable Stage I or IIA
non-small cell lung cancer (NSCLC).
Phase:
Phase 2
Details
Lead Sponsor:
Tianjin Medical University Cancer Institute and Hospital